Key points are not available for this paper at this time.
The performance of our SVE was significantly higher than other machine learning models (RF, ET, GBM) and its major prognostic factors were different. This paper will lead to the development of early risk prediction and diagnosis tool of MACE in ACS patients.
Sherazi et al. (Fri,) studied this question.